Quantum-computing stocks could be rich takeover targets. Here’s what to know.
Innovative startups could be prime acquisition targets for tech giants looking to capitalize on this world-changing application.
Pharma giant Regeneron is spending $119.5M on the world’s largest, most diverse genetic database using DNA from patient volunteers
The Fortune 500 pharma giant will sequence the exomes of 10 million people, with the goal of developing new therapies and ...